Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed question first answered answering member label
tabling member	label

Search

176115

registered interest
date	27/01/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Prescription Drugs: Misuse
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, if he will publish the declarations of interest submitted by members of the expert group with responsibilty for updating the UK guidelines on clinical management of drugs mususe and dependence.
tabling member constituency	Heywood and Middleton
tabling member printed	Liz McInnes
uin	222213
answer	answer is ministerial correction date of answer 03/02/2015 answer text <p>The expert group updating the United Kingdom guidelines for the clinical management of drug misuse and dependence consists of a broad spectrum of stakeholders, including practising clinicians, pharmacists, service users, carers, psychologists, commissioners and academics. Each is required to complete a declaration of interests and keep this updated.</p><p> </p><p> </p><p> </p><p>Public Health England, which provides the secretariat for the group, has reviewed these declarations and on the basis of the information provided believes that no expert group members have a financial interest in the prescribing of specific medicines for the treatment of dependence.</p><p> </p><p> </p><p> </p><p>Clinicians’ declarations will be published alongside the updated clinical guidelines by early 2016.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 03/02/2015 15:23:17 answering member 3918 label Biography information for Jane Ellison
tabling member	4342 label Biography information for Liz McInnes

176116

registered interest
date	27/01/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Prescription Drugs: Misuse
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what steps he plans to take to reduce addiction to prescribed benzodiazepines and z drugs.
tabling member constituency	Heywood and Middleton
tabling member printed	Liz McInnes
uin	222214
answer	answer is ministerial correction date of answer 03/02/2015 answer text <p>Public Health England (PHE), NHS England and others are working together to deliver a wide-ranging programme of work to reduce addiction to medicines. This includes completed work such as publishing a guide to commissioning services to respond to addiction to medicines, factsheets for general practitioners (GPs) (Royal College of General Practitioners) and delivering face-to-face training for GPs and other healthcare workers. Looking ahead, PHE is supporting a number of pilots of improved local commissioning.</p><p> </p><p> </p><p> </p><p>There is now better awareness of these issues among GPs and clearer prescribing guidelines.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 03/02/2015 15:12:03 answering member 3918 label Biography information for Jane Ellison
tabling member	4342 label Biography information for Liz McInnes

176117

registered interest
date	27/01/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Tranquillisers: Misuse
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, if his Department will make an assessment of the implications for its policies of the survey of treatment services provided by local authorities for involuntary tranquilliser addicts conducted by the All Party Parliamentary Group on Involuntary Tranquilliser Addiction.
tabling member constituency	Heywood and Middleton
tabling member printed	Liz McInnes
uin	222215
answer	answer is ministerial correction date of answer 03/02/2015 answer text <p>The Department has taken into account the All Party Parliamentary Group on Involuntary Tranquilliser Addiction’s survey in its deliberations in this policy area.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 03/02/2015 15:13:54 answering member 3918 label Biography information for Jane Ellison
tabling member	4342 label Biography information for Liz McInnes

176118

registered interest
date	27/01/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Prescription Drugs: Misuse
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what steps he plans to take to ensure that patients prescribed benzodiazepines and z drugs are provided with recent Medicines and Healthcare Regulatory Authority advice on those drugs' addiction potential and the time taken to withdraw safely from taking such drugs.
tabling member constituency	Heywood and Middleton
tabling member printed	Liz McInnes
uin	222212
answer	answer is ministerial correction date of answer 03/02/2015 answer text <p>The Medicines and Healthcare products Regulatory Agency (MHRA) has not recently issued any new advice on the addiction potential or the safe withdrawal from benzodiazepines or “z drugs”.</p><p> </p><p> </p><p> </p><p>Benzodiazepines and “z drugs” (zaleplon, zolpidem and zopiclone) are recognised to be associated with an addiction potential particularly when taken for longer than the recommended 2-4 weeks. Over the years action has been taken by the MHRA, the Department of Health and professional bodies to provide extensive warnings about the risks of dependence, limit prescribing and issue advice about gradual withdrawal.</p><p> </p><p> </p><p> </p><p>The risk of dependence on a benzodiazepine (or zaleplon, zolpidem and zopiclone) can increase with higher doses and longer duration of use; therefore, the time it takes to completely stop the medicine varies and withdrawal programmes may sometimes need to be individually tailored.</p><p> </p><p> </p><p> </p><p>Patients receive a patient information leaflet in their pack of benzodiazepine (or zaleplon, zolpidem and zopiclone). The leaflet includes information and advice about their medicine, which will support the vital discussions they have with their doctor and pharmacist about their treatment or stopping treatment.</p><p> </p><p> </p><p> </p><p>Benzodiazepines and “z drugs” are considered acceptably safe and effective when used in accordance with the approved indications and for the recommended duration of use.</p><p> </p><p> </p><p> </p><p>An online learning module for healthcare professionals on benzodiazepines was published on the MHRA’s website in March 2013. The module’s section on dependence and withdrawal gives general guidance on the principles of benzodiazepine withdrawal. The online learning module reflects the product information for these medicines.</p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 03/02/2015 14:55:48 answering member 4020 label Biography information for George Freeman
tabling member	4342 label Biography information for Liz McInnes